» Articles » PMID: 10708812

The Current Status of the Platelet 5-HT(2A) Receptor in Depression

Overview
Journal J Affect Disord
Date 2000 Mar 10
PMID 10708812
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The author reviews the current status of the platelet serotonin (5-HT)(2A) receptor in depression. Considered are studies of receptor binding, and 5-HT-induced platelet activation and aggregation. 5-HT(2A) receptor density tends to increase in depression, although this more clearly relates to suicidality than depression per se. Indeed, data are consistent with the hypothesis that increased density of platelet 5-HT(2A) receptors may be a marker for increased risk of suicide. 5-HT-induced calcium mobilization is enhanced in unipolar depression; however, unlike in bipolar depression, baseline calcium levels are not. Despite inconsistencies, 5-HT-induced aggregation appears inhibited in depression. This may manifest as a relative inhibition, i.e. no change in aggregation response despite a higher density of 5-HT(2A) receptors. The inhibited aggregation response is state dependent, and acute phase proteins or components of the stress response may be factors. It is unclear if differences between depressed and normal subjects in disposition of 5-HT(2A) receptors are generally indicative of traits or states. Nonetheless, there is little evidence that the degree of departure from normal density or activity of platelet of 5-HT(2A) receptors reflects severity of depression.

Citing Articles

High level of systemic immune inflammation index elevates delirium risk among patients in intensive care unit.

Xu F, Zhang S, Zhang Y Sci Rep. 2024; 14(1):30265.

PMID: 39632969 PMC: 11618353. DOI: 10.1038/s41598-024-81559-9.


The impact of depression on platelet activation, cardiocerebral vascular events and arteriovenous fistula dysfunction in patients undergoing haemodialysis.

Xu Y, Zhang S, Xia W, Xiong Y, Wang X, Liu Y Sci Rep. 2024; 14(1):20569.

PMID: 39232077 PMC: 11375179. DOI: 10.1038/s41598-024-71490-4.


Electroconvulsive therapy improves hematological inflammatory markers in bipolar disorder.

Ali E, Embaby A, Arafa S, Elbana A, Ghazala M, Ibrahim D Psychopharmacology (Berl). 2023; 241(2):351-357.

PMID: 37999745 DOI: 10.1007/s00213-023-06491-8.


Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J Pharmaceuticals (Basel). 2021; 14(12).

PMID: 34959614 PMC: 8704767. DOI: 10.3390/ph14121213.


Peripheral Markers of Depression.

Nobis A, Zalewski D, Waszkiewicz N J Clin Med. 2020; 9(12).

PMID: 33255237 PMC: 7760788. DOI: 10.3390/jcm9123793.